Merck & Co Inc

NYSE:MRK  
92.44
+1.27 (+1.39%)
Equity Investments, Mergers / Acquisitions

Merck Eyes Purchase Of Biotech Seagen- WSJ

Published: 06/17/2022 14:37 GMT
Merck & Co Inc (MRK) - Merck Eyes Purchase of Biotech Seagen- Wsj.
Other Unnamed Suitors Are Also Eying Seagen - Wsj.